These mediators of inflammation and oxidative stress can activate or suppress cellular signaling pathways, promoting tumor advancement, metastasis, and immune evasion, including through the PD-1/PD-L1 pathway [41]. This evidence concerns the gene PDCD1 and neoplasm.